Table 3 Intention to treat (ITT) Results and between group ANCOVA analyses immediately following treatment (2 weeks), and repeated measures at follow up (10 weeks). Analyses used are specified within table

 COPM PER

Splint

4.54

3.72–5.36

p = 0.052

COOP

4.47

3.65–5.29

CO-OP + Splint

5.25

4.43–6.07

 COPM SAT

Splint

5.02

4.15–5.88

p = 0.756

COOP

5.35

4.48–6.21

CO-OP + Splint

5.45

4.59–6.32

 GAS

Splint

33.76

28.75–38.76

p = 0.072

COOP

40.85

35.84–45.86

CO-OP + Splint

41.04

36.03–46.05

 COPM PER

Splint

5.41

4.24–6.59

Splint – COOP p = 0.371

COOP

6.17

4.95–7.40

Splint – CO-OP + splint p = 0.618

CO-OP + Splint

5.83

4.62–7.05

COOP – CO-OP + Splint p = 0.702

 COPM SAT

Splint

5.79

4.70–6.89

Splint – COOP p = 0.268

COOP

6.66

5.55–7.76

Splint – CO-OP + Splint p = 0.647

CO-OP + Splint

6.15

5.04–7.25

COOP – CO-OP + Splint p = 0.518

 GAS

Splint

39.12

32.23–46.91

Splint – COOP p = 0.034

COOP

51.16

43.32–59.00

Splint – CO-OP + Splint p = 0.047

CO-OP + Splint

50.29

42.50–58.08

COOP – CO-OP + Splint p = 0.875

 BBT

Splint

11.97

10.55–13.40

Splint – COOP p = 0.047

COOP

14.02

12.60–15.45

Splint – CO-OP + Splint p = 0.250

CO-OP + Splint

13.14

11.71–14.57

COOP – CO-OP + Splint p = 0.382

 PROM^a

Splint

62.00

52.21–71.59

Splint – COOP p = 0.893

COOP

60.94

50.57–71.32

Splint – CO-OP + Splint p = 0.932

CO-OP + Splint

62.48

52.84–72.13

COOP – CO-OP + Splint p = 0.827

 WROM^a

Splint

34.35

22.93–45.76

Splint – COOP p = 0.482

COOP

28.50

16.29–40.70

Splint – CO-OP + Splint p = 0.661

CO-OP + Splint

30.64

18.29–42.99

COOP – CO-OP + Splint p = 0.804

 Volkmann’s angle^a

Splint

42.25

21.90–62.60

Splint – COOP p = 0.461

COOP

31.25

9.36–53.14

Splint – CO-OP + Splint p = 0.550

CO-OP + Splint

33.69

13.32–54.01

COOP – CO-OP + Splint p = 0.871